Abstract
(Abstracted from Obstet Gynecol 2023;142:242–250) A few years ago, the ARRIVE trial (A Randomized Trail of Induction Versus Expectant Management) reported that elective induction of labor at 39 weeks of gestation in low-risk nulliparous patients decreased the risk of cesarean birth and of hypertensive disorders of pregnancy compared with expectant management. This presented a possible means to decrease the high rates of cesarean delivery among this patient group.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
